Charles River Laboratories CRL Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's accrued liabilities, current?
- Charles River Laboratories (CRL) reported accrued liabilities, current of $372.4M in Q1 2026.
- How has Charles River Laboratories's accrued liabilities, current changed year-over-year?
- Charles River Laboratories's accrued liabilities, current increased by 53.6% year-over-year, from $242.47M to $372.4M.
- What is the long-term trend for Charles River Laboratories's accrued liabilities, current?
- Over 5 years (2020 to 2025), Charles River Laboratories's accrued liabilities, current has grown at a 12.5% compound annual growth rate (CAGR), from $149.82M to $270.09M.